Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
PharmacoEconomics
Published in: PharmacoEconomics 5/1998

01-05-1998 | Original Research Article

Cost Analysis of the Treatment of Schizophrenia in the UK

A Comparison of Olanzapine and Haloperidol

Authors: Dr Stephen Almond, Owen O’ Donnell

Published in: PharmacoEconomics | Issue 5/1998

Login to get access
Metadata
Title
Cost Analysis of the Treatment of Schizophrenia in the UK
A Comparison of Olanzapine and Haloperidol
Authors
Dr Stephen Almond
Owen O’ Donnell
Publication date
01-05-1998
Publisher
Springer International Publishing
Published in
PharmacoEconomics / Issue 5/1998
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI
https://doi.org/10.2165/00019053-199813050-00010

Other articles of this Issue 5/1998

PharmacoEconomics 5/1998 Go to the issue

Correspondence

Correspondence

Correspondence

How to Calculate Indirect Costs in Economic Evaluations

Leading Article

The Use of the Bootstrap Statistical Method for the Pharmacoeconomic Cost Analysis of Skewed Data

Original Research Article

The Economic Cost of Multiple Sclerosis in Sweden in 1994

Original Research Article

Predicting Hospitalisation of Patients with Diabetes Mellitus

Current Opinion

Reassessing the Relevance of Pharmacoeconomic Analyses in Formulary Decisions